Risks and benefits of phase 1 oncology trials, 1991 through 2002.
Horstmann E, McCabe MS, Grochow L, Yamamoto S, Rubinstein L, Budd T, Shoemaker D, Emanuel EJ, Grady C.
Horstmann E, et al. Among authors: budd t.
N Engl J Med. 2005 Mar 3;352(9):895-904. doi: 10.1056/NEJMsa042220.
N Engl J Med. 2005.
PMID: 15745980
Free article.